Extracorporeal shockwave therapy in the treatment of erectile dysfunction: A prospective, randomized, double-blinded, placebo controlled study

International Journal of Urology

Volumn 21, Issue 10, 2014, Pages 1041-1045

  Yee, Chi Hang ^a   Chan, Eddie S Y ^a   Hou, Simon See Ming ^a   Ng, Chi Fai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Andrology; Erectile dysfunction; Randomized controlled trial; Shockwave therapy

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; ERECTION HARDNESS SCORE; EXTRACORPOREAL LITHOTRIPSY; FOLLOW UP; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOW INTENSITY EXTRACORPOREAL SHOCKWAVE THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEXUAL HEALTH INVENTORY FOR MEN INTERNATIONAL INDEX OF ERECTILE FUNCTION ERECTILE DYSFUNCTION DOMAIN SCORE; SHAM PROCEDURE; SMOKING; TREATMENT DURATION; AGED; PENIS ERECTION; QUESTIONNAIRE; RADIATION; SEVERITY OF ILLNESS INDEX; THERAPEUTIC USE;

AGED; DOUBLE-BLIND METHOD; ERECTILE DYSFUNCTION; HIGH-ENERGY SHOCK WAVES; HUMANS; MALE; MIDDLE AGED; PENILE ERECTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84908030647     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12506     Document Type: Article

References (12)

1. Shamloul R, Ghanem H. Erectile dysfunction. Lancet 2013; 381: 153-65.
2. Eardley I, Donatucci C, Corbin J et al. Pharmacotherapy for erectile dysfunction. J. Sex. Med. 2010; 7 (1 Pt 2): 524-40.
3. Herrmann HC, Levine LA, Macaluso J Jr et al. Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results. J. Sex. Med. 2006; 3: 303-8.
4. Ng CF, Lee CP, Ho AL, Lee VW. Effect of niacin on erectile function in men suffering erectile dysfunction and dyslipidemia. J. Sex. Med. 2011; 8: 2883-93.
5. Nishida T, Shimokawa H, Oi K et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004; 110: 3055-61.
6. Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J. Urol. 2012; 187: 1769-75.
7. Gutersohn A, Caspari G, Vopahl M, Erbel R. Upregulation of VEGF mRNA in HUVEC via shock Waves. Proceedings of the International Conference From Genes to Therapy in Ischemic and Heart Muscle Disease, Marburg, Germany, 1999.
8. Wang CJ, Wang FS, Yang KD et al. Shock wave therapy induces neovascularization at the tendon-bone junction. A study in rabbits. J. Orthop. Res. 2003; 21: 984-9.
9. Gruenwald I, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy - a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J. Sex. Med. 2012; 9: 259-64.
10. Wang CJ, Huang HY, Pai CH. Shock wave-enhanced neovascularization at the tendon-bone junction: an experiment in dogs. J. Foot Ankle Surg. 2002; 41: 16-22.
11. Taylor J, Baldo OB, Storey A, Cartledge J, Eardley I. Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors. BJU Int. 2009; 103: 1392-5.
12. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int. J. Impot. Res. 1999; 11: 319-26.